Taken together, these data not only postulate c-ABL as a possible therapeutic target for DENV-induced vascular leakage but also point to the existence of c-ABL-dependent trans-differentiation events that potentially mediate DENV infection and the pathogenesis of severe dengue. This evidence concerns the gene ABL1 and dengue disease.